Cargando…

Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()

BACKGROUND: Women are underrepresented in major atrial fibrillation (AF) trials. In addition, data regarding clinical profile and outcome in young AF patients is limited. Therefore we aimed to investigate the clinical profile, AF progression rate and cardiovascular outcome between sexes in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcos, Ernaldo G., De With, Ruben R., Mulder, Bart A., Van Gelder, Isabelle C., Rienstra, Michiel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923497/
https://www.ncbi.nlm.nih.gov/pubmed/31890859
http://dx.doi.org/10.1016/j.ijcha.2019.100429
_version_ 1783481547676975104
author Marcos, Ernaldo G.
De With, Ruben R.
Mulder, Bart A.
Van Gelder, Isabelle C.
Rienstra, Michiel
author_facet Marcos, Ernaldo G.
De With, Ruben R.
Mulder, Bart A.
Van Gelder, Isabelle C.
Rienstra, Michiel
author_sort Marcos, Ernaldo G.
collection PubMed
description BACKGROUND: Women are underrepresented in major atrial fibrillation (AF) trials. In addition, data regarding clinical profile and outcome in young AF patients is limited. Therefore we aimed to investigate the clinical profile, AF progression rate and cardiovascular outcome between sexes in patients with young-onset AF. METHODS: A total of 497 patients with AF-onset <60 years of age were included. Data on clinical profile and cardiovascular outcome were prospectively collected. RESULTS: Of 497 patients, 125 (25%) patients were women. Women had more often familial AF (34% versus 22%, P = 0.012) and obesity (26% versus 18%, P = 0.03). Men had more often coronary artery disease (11% versus 5%, P = 0.04), a longer PR interval [163 (148–180) versus 150 (138–167) ms, P < 0.001] and higher left ventricular mass index [82 (71–96) versus 72 (61–83) g/m(2), P < 0.001]. During a median follow-up of 7.0 (2.7–10.0) years AF progression rate was comparable (HR 2.03 for men versus women, 95%CI 0.92–4.48; P = 0.08), and no difference in cardiovascular events was observed between women and men (Log rank P-value = 0.07). CONCLUSIONS: In young patients with AF, clinical patient profile is different between the sexes but did not result in differences in cardiovascular outcome.
format Online
Article
Text
id pubmed-6923497
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69234972019-12-30 Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome() Marcos, Ernaldo G. De With, Ruben R. Mulder, Bart A. Van Gelder, Isabelle C. Rienstra, Michiel Int J Cardiol Heart Vasc Original Paper BACKGROUND: Women are underrepresented in major atrial fibrillation (AF) trials. In addition, data regarding clinical profile and outcome in young AF patients is limited. Therefore we aimed to investigate the clinical profile, AF progression rate and cardiovascular outcome between sexes in patients with young-onset AF. METHODS: A total of 497 patients with AF-onset <60 years of age were included. Data on clinical profile and cardiovascular outcome were prospectively collected. RESULTS: Of 497 patients, 125 (25%) patients were women. Women had more often familial AF (34% versus 22%, P = 0.012) and obesity (26% versus 18%, P = 0.03). Men had more often coronary artery disease (11% versus 5%, P = 0.04), a longer PR interval [163 (148–180) versus 150 (138–167) ms, P < 0.001] and higher left ventricular mass index [82 (71–96) versus 72 (61–83) g/m(2), P < 0.001]. During a median follow-up of 7.0 (2.7–10.0) years AF progression rate was comparable (HR 2.03 for men versus women, 95%CI 0.92–4.48; P = 0.08), and no difference in cardiovascular events was observed between women and men (Log rank P-value = 0.07). CONCLUSIONS: In young patients with AF, clinical patient profile is different between the sexes but did not result in differences in cardiovascular outcome. Elsevier 2019-11-07 /pmc/articles/PMC6923497/ /pubmed/31890859 http://dx.doi.org/10.1016/j.ijcha.2019.100429 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Paper
Marcos, Ernaldo G.
De With, Ruben R.
Mulder, Bart A.
Van Gelder, Isabelle C.
Rienstra, Michiel
Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()
title Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()
title_full Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()
title_fullStr Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()
title_full_unstemmed Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()
title_short Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()
title_sort young-onset atrial fibrillation: sex differences in clinical profile, progression rate and cardiovascular outcome()
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923497/
https://www.ncbi.nlm.nih.gov/pubmed/31890859
http://dx.doi.org/10.1016/j.ijcha.2019.100429
work_keys_str_mv AT marcosernaldog youngonsetatrialfibrillationsexdifferencesinclinicalprofileprogressionrateandcardiovascularoutcome
AT dewithrubenr youngonsetatrialfibrillationsexdifferencesinclinicalprofileprogressionrateandcardiovascularoutcome
AT mulderbarta youngonsetatrialfibrillationsexdifferencesinclinicalprofileprogressionrateandcardiovascularoutcome
AT vangelderisabellec youngonsetatrialfibrillationsexdifferencesinclinicalprofileprogressionrateandcardiovascularoutcome
AT rienstramichiel youngonsetatrialfibrillationsexdifferencesinclinicalprofileprogressionrateandcardiovascularoutcome